USX:BRLI - Bio-Reference Laboratories Inc (USD 34.61) Bio-Reference Laboratories Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance
Note: This stock seems to be inactive

USD 34.61    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

20 Aug 2015


20 Aug 2015

Day Change: 0 (0%)

52 Wk Range: 26.32 - 47.49

Day's Range: 34.61 - 34.61

Last Volume: 200

Current Yield: 0%

Projected Yield: 0%

Open: USD 34.61

Metric BRLI S.Median
Beta NA NA
E.Shortfall NA NA
Liquidity NA NA


20 Aug 2015

PE: 19.062

Market Cap: 965M

Price Over Book: 2.866

Price Over Sales: 1.09

Return On Assets: 9.9%

Return On Equity: 15%

Price Over NAV: [Friends Only]


CEO: Marc D. Grodman

Headquarters: ELMWOOD PARK

Employees: 3,406

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases in the United States. The company focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, womenÂ’s health, and correctional health care services. It offers chemical diagnostic tests, such as blood and urine analysis; blood chemistry; hematology services; serology; radio-immuno analysis; toxicology, including drug screening; pap smears; tissue pathology comprising biopsies; and other tissue analysis, as well as cancer cytogenetic testing, genetic testing, and cytology testing services. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. It serves physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is headquartered in Elmwood Park, New Jersey.